Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100QPSY
Period2022-10-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Revenue¥8.5bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥4.4bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Operating income¥867m2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥1.1bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥890m2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥812m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥599m2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Net income¥618m2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥14.5bnat 2023-03-31Cons.Assets
Total assets¥9.4bnat 2022-09-30Cons.Assets
Total assets¥9.2bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2023-03-31Cons.Liabilities
Total liabilities¥1.5bnat 2022-09-30Cons.Liabilities
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.7bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥853m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥538m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥423m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥7m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥21m2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.622021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.742021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.572022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.782021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.262021-10-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-03-31−¥645m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥202m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥199m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥30m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥137m
—segment totalrevenue2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue intersegment2021-10-01 → 2022-03-31¥7m
—segment totalsegment profit2021-10-01 → 2022-03-31¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Selling general and administrative expensesCurrentYTDDuration2808721000JPY
Operating incomePrior1YTDDuration866859000JPY
Operating incomeCurrentYTDDuration716967000JPY
Interest income noiPrior1YTDDuration114000JPY
Interest income noiCurrentYTDDuration99000JPY
Equity in earnings of affiliates noiPrior1YTDDuration22689000JPY
Equity in earnings of affiliates noiCurrentYTDDuration26219000JPY
Subsidy income noiPrior1YTDDuration463000JPY
Subsidy income noiCurrentYTDDuration1043000JPY
Other noiPrior1YTDDuration1473000JPY
Other noiCurrentYTDDuration1276000JPY
Non operating incomePrior1YTDDuration24740000JPY
Non operating incomeCurrentYTDDuration28638000JPY
Interest expenses noePrior1YTDDuration452000JPY
Interest expenses noeCurrentYTDDuration6845000JPY
Foreign exchange losses noePrior1YTDDuration5000JPY
Foreign exchange losses noeCurrentYTDDuration294000JPY
Consumption tax difference noePrior1YTDDuration1177000JPY
Consumption tax difference noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration129000JPY
Other noeCurrentYTDDuration3383000JPY
Non operating expensesPrior1YTDDuration1764000JPY
Non operating expensesCurrentYTDDuration10523000JPY
Ordinary incomePrior1YTDDuration889835000JPY
Ordinary incomeCurrentYTDDuration735082000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration47000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration47000JPY
Extraordinary incomeCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration889882000JPY
Income before income taxesCurrentYTDDuration735082000JPY
Income taxes currentPrior1YTDDuration259987000JPY
Income taxes currentCurrentYTDDuration288755000JPY
Income taxes deferredPrior1YTDDuration12296000JPY
Income taxes deferredCurrentYTDDuration55682000JPY
Income taxesPrior1YTDDuration272283000JPY
Income taxesCurrentYTDDuration344438000JPY
Profit lossPrior1YTDDuration617598000JPY
Profit lossCurrentYTDDuration390644000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration18977000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration10233000JPY
Profit loss attributable to owners of parentPrior1YTDDuration598620000JPY
Profit loss attributable to owners of parentCurrentYTDDuration380411000JPY
Profit lossPrior1YTDDuration617598000JPY
Profit lossCurrentYTDDuration390644000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-3605000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-647000JPY
Other comprehensive incomePrior1YTDDuration-3605000JPY
Other comprehensive incomeCurrentYTDDuration-647000JPY
Comprehensive incomePrior1YTDDuration613993000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass